These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 38472195)
1. Elevated Kallistatin promotes the occurrence and progression of non-alcoholic fatty liver disease. Fang Z; Shen G; Wang Y; Hong F; Tang X; Zeng Y; Zhang T; Liu H; Li Y; Wang J; Zhang J; Gao A; Qi W; Yang X; Zhou T; Gao G Signal Transduct Target Ther; 2024 Mar; 9(1):66. PubMed ID: 38472195 [TBL] [Abstract][Full Text] [Related]
2. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet. Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140 [TBL] [Abstract][Full Text] [Related]
3. Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. Simon Y; Kessler SM; Gemperlein K; Bohle RM; Müller R; Haybaeck J; Kiemer AK World J Gastroenterol; 2014 Dec; 20(47):17839-50. PubMed ID: 25548482 [TBL] [Abstract][Full Text] [Related]
4. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis. Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621 [TBL] [Abstract][Full Text] [Related]
5. TXNIP/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation. Park HS; Song JW; Park JH; Lim BK; Moon OS; Son HY; Lee JH; Gao B; Won YS; Kwon HJ Autophagy; 2021 Sep; 17(9):2549-2564. PubMed ID: 33190588 [TBL] [Abstract][Full Text] [Related]
6. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease. Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831 [TBL] [Abstract][Full Text] [Related]
7. Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia. Jha P; Claudel T; Baghdasaryan A; Mueller M; Halilbasic E; Das SK; Lass A; Zimmermann R; Zechner R; Hoefler G; Trauner M Hepatology; 2014 Mar; 59(3):858-69. PubMed ID: 24002947 [TBL] [Abstract][Full Text] [Related]
8. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476 [TBL] [Abstract][Full Text] [Related]
9. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1. Wu L; Liu Y; Zhao Y; Li M; Guo L Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490 [TBL] [Abstract][Full Text] [Related]
11. The ménage à trois of autophagy, lipid droplets and liver disease. Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741 [TBL] [Abstract][Full Text] [Related]
12. Involvement of G protein-coupled receptor kinase 2 (GRK2) in the development of non-alcoholic steatosis and steatohepatitis in mice and humans. Cruces-Sande M; Vila-Bedmar R; Arcones AC; González-Rodríguez Á; Rada P; Gutiérrez-de-Juan V; Vargas-Castrillón J; Iruzubieta P; Sánchez-González C; Formentini L; Crespo J; García-Monzón C; Martínez-Chantar ML; Valverde ÁM; Mayor F; Murga C Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3655-3667. PubMed ID: 30261289 [TBL] [Abstract][Full Text] [Related]
13. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555 [TBL] [Abstract][Full Text] [Related]
14. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor. Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835 [TBL] [Abstract][Full Text] [Related]
15. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease. Li X; Wang Z; Klaunig JE Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929 [TBL] [Abstract][Full Text] [Related]
16. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet. Tanaka N; Takahashi S; Zhang Y; Krausz KW; Smith PB; Patterson AD; Gonzalez FJ Biochim Biophys Acta; 2015 Jul; 1852(7):1242-52. PubMed ID: 25736301 [TBL] [Abstract][Full Text] [Related]
17. Experimental Nonalcoholic Steatohepatitis and Liver Fibrosis Are Ameliorated by Pharmacologic Activation of Nrf2 (NF-E2 p45-Related Factor 2). Sharma RS; Harrison DJ; Kisielewski D; Cassidy DM; McNeilly AD; Gallagher JR; Walsh SV; Honda T; McCrimmon RJ; Dinkova-Kostova AT; Ashford MLJ; Dillon JF; Hayes JD Cell Mol Gastroenterol Hepatol; 2018 Mar; 5(3):367-398. PubMed ID: 29552625 [TBL] [Abstract][Full Text] [Related]
19. Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. Zhang X; Li S; Zhou Y; Su W; Ruan X; Wang B; Zheng F; Warner M; Gustafsson JÅ; Guan Y Proc Natl Acad Sci U S A; 2017 Mar; 114(12):3181-3185. PubMed ID: 28270609 [TBL] [Abstract][Full Text] [Related]
20. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD. Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]